BAXAQUEL Trademark

Trademark Overview

On Tuesday, January 29, 2013, a trademark application was filed for BAXAQUEL with the United States Patent and Trademark Office. The USPTO has given the BAXAQUEL trademark a serial number of 85835257. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, May 5, 2023. This trademark is owned by Glaxo Group Limited. The BAXAQUEL trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines
baxaquel

General Information

Serial Number85835257
Word MarkBAXAQUEL
Filing DateTuesday, January 29, 2013
Status710 - CANCELLED - SECTION 8
Status DateFriday, May 5, 2023
Registration Number5066640
Registration DateTuesday, October 25, 2016
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 18, 2013

Trademark Statements

Goods and ServicesPharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines
Translation of Words in MarkThe wording "BAXAQUEL" has no meaning in a foreign language.

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, May 5, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGlaxo Group Limited
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressBrentford, Middlesex TW89GS
GB
Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBrentford, Middlesex TW89GS
GB
Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBrentford, Middlesex TW89GS
GB

Trademark Events

Event DateEvent Description
Friday, May 5, 2023CANCELLED SEC. 8 (6-YR)
Friday, October 28, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, October 28, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, October 28, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, October 25, 2021COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, October 25, 2016REGISTERED-PRINCIPAL REGISTER
Wednesday, September 21, 2016ELECTRONIC RECORD REVIEW COMPLETE
Friday, August 19, 2016ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
Monday, August 15, 2016WITHDRAWN FROM ISSUE(NOA)-ITU REQUEST
Friday, August 5, 20161(B) BASIS DELETED; PROCEED TO REGISTRATION
Thursday, August 4, 2016NOTICE OF ALLOWANCE CANCELLED
Thursday, August 4, 2016TEAS POST PUBLICATION AMENDMENT RECEIVED
Wednesday, February 24, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, February 23, 2016SOU EXTENSION 5 GRANTED
Thursday, February 11, 2016SOU EXTENSION 5 FILED
Thursday, February 11, 2016TEAS EXTENSION RECEIVED
Wednesday, August 5, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, August 4, 2015SOU EXTENSION 4 GRANTED
Thursday, July 23, 2015SOU EXTENSION 4 FILED
Thursday, July 23, 2015TEAS EXTENSION RECEIVED
Tuesday, December 9, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, December 8, 2014SOU EXTENSION 3 GRANTED
Tuesday, November 18, 2014SOU EXTENSION 3 FILED
Tuesday, November 18, 2014TEAS EXTENSION RECEIVED
Thursday, August 14, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, August 13, 2014SOU EXTENSION 2 GRANTED
Friday, March 14, 2014SOU EXTENSION 2 FILED
Thursday, August 7, 2014CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, July 14, 2014TEAS EXTENSION RECEIVED
Thursday, February 13, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, February 11, 2014SOU EXTENSION 1 GRANTED
Tuesday, February 11, 2014SOU EXTENSION 1 FILED
Tuesday, February 11, 2014TEAS EXTENSION RECEIVED
Tuesday, August 13, 2013NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, June 18, 2013OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 18, 2013PUBLISHED FOR OPPOSITION
Wednesday, May 29, 2013NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, May 13, 2013ELECTRONIC RECORD REVIEW COMPLETE
Friday, May 10, 2013ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
Monday, May 6, 2013APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, May 2, 2013ASSIGNED TO EXAMINER
Wednesday, March 20, 2013APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, March 20, 2013TEAS CHANGE OF OWNER ADDRESS RECEIVED
Monday, February 4, 2013NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, February 1, 2013NEW APPLICATION ENTERED

Related Keywords

baxaquel pharmaceutical treatment disorders preparations substances diseases ophthalmic respiratory hepatological oncological